Caitlin Kontulis - Feb 15, 2023 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Secretary & VP Finance & Admin
Signature
Caitlin Kontulis
Stock symbol
PHIO
Transactions as of
Feb 15, 2023
Transactions value $
-$3,416
Form type
4
Date filed
2/17/2023, 05:30 PM
Previous filing
Mar 3, 2022
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Tax liability -$3.42K -657 -7.59% $5.20 7.99K Feb 15, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold.
F2 Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12.